Evidence map›Paper›PMID 31979108›Full record

ReviewInternational journal of molecular sciences2020

Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?

Pierangelo Cifelli, Gabriele Ruffolo, Eleonora De Felice, Veronica Alfano, Erwin Alexander van Vliet, Eleonora Aronica, Eleonora Palma

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Cys-loop receptors on cannabinoids: All high?Frontiers in physiology · 2022
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The Use of Compounds Derived fromInternational journal of molecular sciences · 2024
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Observational
  19. Article
  20. The effects of cannabis and cannabinoids on the endocrine system.Reviews in endocrine & metabolic disorders · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pierangelo CifelliIRCCS Neuromed, Pozzilli, 86077 Isernia, Italy.
Gabriele RuffoloIRCCS San Raffaele Pisana, 00163 Rome, Italy.
Eleonora De FeliceIRCCS San Raffaele Pisana, 00163 Rome, Italy.
Veronica AlfanoDepartment of Physiology and Pharmacology, laboratory affiliated to Istituto Pasteur Italia, University of Rome Sapienza, 00185 Rome, Italy.
Erwin Alexander van VlietAmsterdam UMC, University of Amsterdam, Department of (Neuro) Pathology, 1105 Amsterdam, The Netherlands.
Eleonora AronicaAmsterdam UMC, University of Amsterdam, Department of (Neuro) Pathology, 1105 Amsterdam, The Netherlands.
Eleonora PalmaDepartment of Physiology and Pharmacology, laboratory affiliated to Istituto Pasteur Italia, University of Rome Sapienza, 00185 Rome, Italy.

Funding

AICE-FIRE 2018EPITARGET 602102European Union's Seventh Framework Program FP7/2007-2013UCB-PHARMA IIS-2014-101617
6 · The paper itself

Abstract

γ-Aminobutyric acid type A receptors (GABA

Indexed as

AnimalsCannabidiolCannabinoidsHumansNervous System DiseasesReceptors, GABA-ACannabidiolCannabinoidsReceptors, GABA-Acannabinoidsendocannabinoid systemGABAARsneurotransmission

Identifiers

PMID31979108
PMCPMC7038116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.